Heart pump support for shock after a heart attack
Part of Heart & circulation clinical trials.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had a recent heart attack that caused cardiogenic shock (when the heart can't pump enough blood to the body).
- Your blood pressure is low (below 100 mmHg) or you need medication to keep it above 90.
- You have a high lactate level in your blood (above 2.0 mmol/L), which indicates poor blood flow.
- An ultrasound shows your heart's pumping ability is less than 40% or blood flow out of the heart is very low.
- You do not have other causes of shock (like severe dehydration, sepsis, or a blood clot in the lungs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a temporary heart pump helps people who have had a heart attack complicated by cardiogenic shock. The pump supports the heart while doctors restore blood flow, which may improve recovery.
This trial tests a new heart pump device (CorVad) to support the heart in people who are in cardiogenic shock after a heart attack. It may help stabilize blood pressure and improve blood flow, potentially giving the heart time to recover.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
This study is testing a device called an intra-aortic balloon pump (a small balloon placed in your heart's main artery to help it pump) for people in the early stages of cardiogenic shock, a condition where the heart can't pump enough blood. The goal is to see if adding this supportive device early on improves outcomes for patients with heart attacks or other heart problems.
This trial tests whether a temporary heart pump (called an intra-aortic balloon pump, or IABP) helps people who have a hole in the heart after a heart attack. The pump is placed in the main artery to help your heart pump blood more effectively.
This study examines detailed data from patients who received an Impella 5.5 heart pump to treat cardiogenic shock—a life-threatening condition where the heart cannot pump enough blood. Researchers use advanced computer analysis to understand what helps patients recover best.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.